A common antidepressant shows promise in reducing methamphetamine use in a large Australian trial. The study indicates that mirtazapine led to fewer days of meth use over 12 weeks compared with placebo, offering a potential pharmacological option in the absence of approved medications. The findings suggest a direct effect on brain reward pathways beyond mood improvement.

This topic is of interest to psychology readers because it explores how existing medications can influence addictive behaviors and brain reward systems, contributing to understanding treatment approaches for substance use disorders.

Article Title: A common antidepressant shows promise in treating methamphetamine dependence

Link to PsyPost Article: https://www.psypost dot org/a-common-antidepressant-shows-promise-in-treating-methamphetamine-dependence/

Copy and paste broken link above into your browser and replace "dot" with "." for link to work. We have to do it this way to avoid displaying copyrighted images.

#methamphetamine #mirtazapine #substanceuse #psychopharmacology #addictiontreatment

Harvard Gazette: Yoga can help cut severe, initial opioid-withdrawal period in half, study finds . “Just 10 sessions of yoga can cut the length of the initial, most severe period of opioid withdrawal nearly in half, dramatically increasing the odds of successful recovery, new research shows.”

Acadia Healthcare: Examining Its Role in the Behavioral Health Sector

Acadia Healthcare is a big company in mental health care in the U.S. It has many hospitals and clinics. Learn about its services and role.

#AcadiaHealthcare, #MentalHealth, #BehavioralHealth, #Healthcare, #AddictionTreatment

https://newsletter.tf/acadia-healthcare-mental-health-care/